OBJECTIVE: To analyze the survival predictors of patients undergoing hepatectomy for colorectal liver metastasis to determine useful indicators for therapy selection. SUMMARY BACKGROUND DATA: Although recurrence develops in more than two thirds of patients undergoing hepatectomy for colorectal liver metastasis, preoperative characteristics that might predict such recurrence have yet to be clearly identified. METHODS: Clinicopathologic data of 85 consecutive patients with colorectal cancer who underwent a curative resection of primary lesions and metastatic liver diseases at one institute were analyzed using the multivariate method with respect to both the metastatic state and the primary lesion. RESULTS: Multivariate analysis indicated that the aggressiveness of the primary tumor, early liver metastasis, and a large number of liver metastases were the characteristics that could be detected before hepatectomy and that independently indicated a worse survival. A three-ranked classification based on these coefficients (H-staging) was significantly related to both the recurrence rate within 6 months (7% in H-stage A, 30% in B, and 44% in C) and the 5-year survival rates (55%, 14%, and 0% respectively). An additional scoring system (H'-staging) based on the aggressiveness of the primary tumor and the level of carcinoembryonic antigen 1 to 3 months after hepatectomy was found to be related to the mode of subsequent recurrence and surgical resectability of the recurrent foci. CONCLUSIONS: H-staging can provide useful prognostic information for the treatment of liver metastasis. H-staging could also help in predicting the possible mode of recurrence after hepatectomy and in determining the most suitable mode of additional therapy. Further multiinstitutional studies based on a large collective database will confirm the utility of these two staging systems.
OBJECTIVE: To analyze the survival predictors of patients undergoing hepatectomy for colorectal liver metastasis to determine useful indicators for therapy selection. SUMMARY BACKGROUND DATA: Although recurrence develops in more than two thirds of patients undergoing hepatectomy for colorectal liver metastasis, preoperative characteristics that might predict such recurrence have yet to be clearly identified. METHODS: Clinicopathologic data of 85 consecutive patients with colorectal cancer who underwent a curative resection of primary lesions and metastatic liver diseases at one institute were analyzed using the multivariate method with respect to both the metastatic state and the primary lesion. RESULTS: Multivariate analysis indicated that the aggressiveness of the primary tumor, early liver metastasis, and a large number of liver metastases were the characteristics that could be detected before hepatectomy and that independently indicated a worse survival. A three-ranked classification based on these coefficients (H-staging) was significantly related to both the recurrence rate within 6 months (7% in H-stage A, 30% in B, and 44% in C) and the 5-year survival rates (55%, 14%, and 0% respectively). An additional scoring system (H'-staging) based on the aggressiveness of the primary tumor and the level of carcinoembryonic antigen 1 to 3 months after hepatectomy was found to be related to the mode of subsequent recurrence and surgical resectability of the recurrent foci. CONCLUSIONS: H-staging can provide useful prognostic information for the treatment of liver metastasis. H-staging could also help in predicting the possible mode of recurrence after hepatectomy and in determining the most suitable mode of additional therapy. Further multiinstitutional studies based on a large collective database will confirm the utility of these two staging systems.
Authors: K Shirabe; K Takenaka; T Gion; Y Fujiwara; M Shimada; K Yanaga; T Maeda; K Kajiyama; K Sugimachi Journal: Br J Surg Date: 1997-08 Impact factor: 6.939
Authors: B Cady; R L Jenkins; G D Steele; W D Lewis; M D Stone; W V McDermott; J M Jessup; A Bothe; P Lalor; E J Lovett; P Lavin; D C Linehan Journal: Ann Surg Date: 1998-04 Impact factor: 12.969
Authors: K Yasui; T Hirai; T Kato; A Torii; K Uesaka; T Morimoto; Y Kodera; Y Yamamura; T Kito; N Hamajima Journal: Ann Surg Date: 1997-11 Impact factor: 12.969
Authors: T Yamamura; S Tsukikawa; O Akaishi; K Tanaka; H Matsuoka; A Hanai; H Oikawa; T Ozasa; K Kikuchi; H Matsuzaki; S Yamaguchi Journal: Dis Colon Rectum Date: 1997-12 Impact factor: 4.585
Authors: J D Howell; C S McArdle; D J Kerr; J Buckles; J A Ledermann; I Taylor; H J Gallagher; J Budden Journal: Br J Cancer Date: 1997 Impact factor: 7.640
Authors: Wong Hoi She; Albert C Y Chan; Ka Wing Ma; Wing Chiu Dai; Kenneth S H Chok; Tan To Cheung; Chung Mau Lo Journal: J Gastrointest Surg Date: 2018-06-29 Impact factor: 3.452
Authors: Florian M Kovar; Christiane Thallinger; Claudia L Marsik; Thomas Perkmann; Harald Puhalla; Helmuth Haslacher; Fritz Wrba; Oswald F Wagner; Thomas Gruenberger; Georg Endler Journal: Wien Klin Wochenschr Date: 2009 Impact factor: 1.704